4.75 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
AN2 Therapeutics, Inc. Common Stock
ANTXNASDAQ • USD
4.77
↗ 0.02 (0.32%)
POST MARKET (AS OF 05:03 PM EDT)
Post Market
AS OF 05:03 PM EDT
4.77
↗ 0.02 (0.32%)
Market: CLOSED
Open?$4.70
High?$4.95
Low?$4.50
Prev. Close?$4.75
Volume?408.7K
Avg. Volume?302.2K
VWAP?$4.72
Rel. Volume?1.35x
Bid / Ask
Bid?$4.07 × 100
Ask?$5.57 × 100
Spread?$1.50
Midpoint?$4.82
Valuation & Ratios
Market Cap?171.1M
Shares Out?36.0M
Float?25.9M
Float %?72.2%
P/E Ratio?N/A
P/B Ratio?2.09
EPS?-$0.96
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
Themes
Employees
21
Market Cap
171.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2022-03-25
Address
1300 EL CAMINO REAL, SUITE 100
MENLO PARK, CA 94025
Phone: (650) 331-9090
MENLO PARK, CA 94025
Phone: (650) 331-9090
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?15.73Strong
Quick Ratio?15.73Strong
Cash Ratio?9.62Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?2.09CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.2CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-42.3%WEAK▾
ROA?-39.5%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$117.6M
Fundamentals ratios updated end of day